Usefulness of the fractional flow reserve derived by intracoronary pressure wire for evaluating angiographically intermediate lesions in acute coronary syndrome;Utilidad de la reserva fraccional de flujo obtenida mediante guía intracoronaria de presión en la valoración de lesiones angiográficamente moderadas en el síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 63, Issue 6, 2010, Pages 686-694

  López Palop, Ramón ^a   Carrillo, Pilar ^a   Frutos, Araceli ^a   Castillo, Jesús ^a   Cordero, Alberto ^a   Toro, Marlon ^a   Bertomeu Martínez, Vicente ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Coronary angiography; Coronary angioplasty; Coronary disease; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY PRESSURE; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; REVASCULARIZATION;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954988006     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70161-5     Document Type: Article

References (27)

1. N.H. Pijls, B. Van Gelder, P. Van der Voort, K. Peels, F.A. Bracke, and H.J. Bonnier Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow Circulation 92 1995 3183 3193
2. N.H. Pijls, B. De Bruyne, K. Peels, P.H. Van der Voort, H.J. Bonnier, and J.K.J. Bartunek Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses N Engl J Med 334 1996 1703 1708
3. M.J. Kern, A. Lerman, J.W. Bech, B. De Bruyne, E. Eeckhout, and W.F. Fearon Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology Circulation 114 2006 1321 1341
4. N.G. Uren, J.A. Melin, B. De Bruyne, W. Wijns, T. Baudhuin, and P.G. Camici Relation between myocardial blood flow and the severity of coronary- artery stenosis N Engl J Med 330 1994 1782 1788
5. B. De Bruyne, T. Baudhuin, J.A. Melin, N.H. Pijls, S.U. Sys, and A. Bol Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography Circulation 89 1994 1013 1022
6. G.J. Bech, B. De Bruyne, H.J. Bonnier, J. Bartunek, W. Wijns, and K. Peels Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement J Am Coll Cardiol 31 1998 841 847
7. A.J. Domínguez-Franco, M.F. Jiménez-Navarro, A.J. Muñoz-García, J.H. Alonso-Briales, J.M. Hernández- García, and E. De Teresa Galván Pronóstico a largo plazo de diferir la intervención coronaria en diabéticos sobre la base de la reserva fraccional de flujo Rev Esp Cardiol 61 2008 352 359
8. N.H. Pijls, S.P. Van, G. Manoharan, E. Boersma, J.W. Bech, and V.M. Van't Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study J Am Coll Cardiol 49 2007 2105 2111
9. M.J. Kern, T.J. Donohue, F.V. Aguirre, R.G. Bach, E.A. Caracciolo, and T. Wolford Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements J Am Coll Cardiol 25 1995 178 187
10. S.A. Chamuleau, M. Meuwissen, K.T. Koch, B.L. Eck-Smit, R.A. Tio, and J.G. Tijssen Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis Am J Cardiol 89 2002 377 380
11. R.J. Ruiz-Salmerón, M. Sanmartín, R. Mantilla, M. Bravo, R. Castellanos, and J. Goicolea ¿Puede la reserva fraccional de flujo guiar la estrategia terapéutica en el síndrome coronario agudo? Rev Esp Cardiol 56 2003 315 317
12. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, and D.E. Casey Jr ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 50 2007 e1 e157
13. J.M. Potvin, J. Rodes-Cabau, O.F. Bertrand, O. Gleeton, C.N. Nguyen, and G. Barbeau Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or atypical chest pain Am J Cardiol 98 2006 289 297
14. P.A. Tonino, B. De Bruyne, N.H. Pijls, U. Siebert, F. Ikeno, and M. Veer Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
15. J. Tobis, B. Azarbal, and L. Slavin Assessment of intermediate severity coronary lesions in the catheterization laboratory J Am Coll Cardiol 49 2007 839 848
16. V. Magni, A. Chieffo, and A. Colombo Evaluation of intermediate coronary stenosis with intravascular ultrasound and fractional flow reserve: Its use and abuse Catheter Cardiovasc Interv 73 2009 441 448
17. S. Dey, M.D. Flather, G. Devlin, D. Brieger, E.P. Gurfinkel, and P.G. Steg Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events Heart 95 2009 20 26
18. M.A. Leesar, T. Abdul-Baki, N.I. Akkus, A. Sharma, T. Kannan, and R. Bolli Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome J Am Coll Cardiol 41 2003 1115 1121
19. R. López-Palop, E. Pinar, I. Lozano, P. Carrillo, R. Cortes, and F. Pico Utilización habitual de la guía de presión intracoronaria. Experiencia de un centro Rev Esp Cardiol 55 2002 251 257
20. B. De Bruyne, and J. Sarma Fractional flow reserve: a review: invasive imaging Heart 94 2008 949 959
21. B. De Bruyne, N.H. Pijls, E. Barbato, J. Bartunek, J.W. Bech, and W. Wijns Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans Circulation 107 2003 1877 1883
22. A. Jeremias, R.J. Whitbourn, S.D. Filardo, P.J. Fitzgerald, D.J. Cohen, and E.M. Tuzcu Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements Am Heart J 140 2000 651 657
23. A. Jeremias, S.D. Filardo, R.J. Whitbourn, R.S. Kernoff, A.C. Yeung, and P.J. Fitzgerald Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and pressure dynamics Circulation 101 2000 318 323
24. E. Di Segni, S.T. Higano, C.S. Rihal, D.R. Holmes Jr, R. Lennon, and A. Lerman Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making Catheter Cardiovasc Interv 54 2001 34 40
25. R. López-Palop, D. Saura, E. Pinar, I. Lozano, and F. Pérez-Lorente Adequate intracoronary adenosine doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional flow reserve: a dose response study Heart 90 2004 95 96
26. G. Casella, M. Leibig, T.M. Schiele, R. Schrepf, V. Seelig, and H.U. Stempfle Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 148 2004 590 595
27. M.H. Yoon, S.J. Tahk, H.M. Yang, J.S. Park, M. Zheng, and H.S. Lim Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement Am Heart J 157 2009 1050 1056